China-Biotics, Inc. to Present at CCG Investor Relations' China Rising Conference
Posted on: Thursday, 30 April 2009, 07:00 CDT
The date, time and location of China-Biotics' presentation at the China Rising Investment Conference are as follows:
Date: Monday, May 18, 2009 Time: 11:00 a.m. EDT Presenter: Lewis Fan, Chief Financial Officer Venue: The Yale Club 50 Vanderbilt Ave. New York, N.Y. 10017 Webcast: http://www.chinarisingconference.com/webcast.htmlA replay of the webcast will be available for up to one year following the presentation using the same link.
The China Rising Investment Conference hosted by CCG Investor Relations will provide more than 250 fund managers and investors with access to the senior management teams of a wide range of Chinese growth companies in sectors including advanced materials, agriculture, alternative energy, capital goods, consumer staples, information technology, infrastructure and pharmaceuticals. The conference will include more than 30 U.S.-listed Chinese companies and a number of privately held Chinese companies.
Interested parties and investors may find more information for the conference by visiting http://www.chinarisingconference.com .
About China-Biotics, Inc.
China-Biotics, Inc. ("China-Biotics," "the Company"), a leading
manufacturer of biotechnology products and supplements, engages in the
research, development, marketing and distribution of probiotics dietary
supplements. Through its wholly owned subsidiary, Shanghai Shining
Biotechnology Co., Ltd., the Company has operations in
Safe Harbor Statement Under the Private Securities Litigation Reform Act of 1995: Any statements set forth above that are not historical facts are forward-looking statements that involve risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. Such factors include, but are not limited to, the Company's ability to market existing and new products, changes from anticipated levels of sales, future national or regional economic and competitive conditions, market acceptance of its retail store concept, changes in relationships with customers, dependence on its flagship product profits and other factors detailed from time to time in the Company's filings with the United States Securities and Exchange Commission and other regulatory authorities. The Company undertakes no obligation to publicly update or revise any forward- looking statements, whether as a result of new information, future events or otherwise.
For more information, please contact: CCG Investor Relations Crocker Coulson, President Phone: +1-646-213-1915 (New York) Email: crocker.coulson@ccgir.com Web: http://www.ccgirasia.comSOURCE China-Biotics, Inc.
Source: PR Newswire
Related Articles
- China Education Alliance to Present at the RedChip China Equities Conference in Shanghai
- China-Biotics, Inc. Begins Trial Production at New Facility, Affirms 2010 Revenue Guidance
- China-Biotics, Inc. Applies for Four Patents on Probiotic Formulations
- China-Biotics, Inc. Reports Fourth Quarter and Full Year Fiscal 2009 Financial Results
- China-Biotics, Inc. Announces Conference Call to Discuss Fourth Quarter and Full Year 2009 Financial Results
- China-Biotics, Inc. Supplies Probiotics as Additive for Poultry Feed
- China-Biotics Signs Contract With Henan Square Pharmaceutical
- China-Biotics, Inc. Reports Second Quarter 2008 Financial Results
- China-Biotics Announces Record Results for Fiscal 2006; Company Reports Full Year Revenues of $21.9 Million, Up 51.6% Vs. FY05; Gross Margins of 70.7% and Net Income of $8.4 Million
 |
 |
User Comments (0)
RSS Feeds